Sort
21,453 grants matching “tuberculosis”
RNA editing and its inhibition of HIV-1 replication in human macrophage
$205,124Yoshihiko Hoshino · New York University School Of Medicine · R21 · FY2007 · DA
Cyclic AMP secretion mechanisms in M. tuberculosis
$205,091Kathleen A. McDonough · Wadsworth Center · R21 · FY2018 · AI
Direct ligand-based control of C. albicans zinc cluster transcription factors
$205,000Lawrence Christopher Myers · Dartmouth College · R21 · FY2020 · AI
Role of Lung Repair and Regeneration Pathways in Tuberculosis
$205,000Mushtaq Ahmed · University Of Chicago · R21 · FY2025 · AI
Examining the influence of chromosome copy number on Pseudomonas aeruginosa persisters to fluoroquinolones
$205,000Mark P Brynildsen · Princeton University · R21 · FY2025 · AI
Maltoheptaose based nanotherapeutics for multidrug resistant bacterial infection
$204,975Mingdi Yan · University Of Massachusetts Lowell · R21 · FY2014 · AI
An imaging approach to understanding the impact of heterogeneity in microenvironments and lesion properties during Mycobacterium tuberculosis infection
$204,950Shumin Tan · Tufts University Boston · R21 · FY2020 · AI
Caribbean, Central, and South America network for HIV Epidemiology (CCASAnet)
$204,915Jessica L Castilho · Vanderbilt University Medical Center · U01 · FY2025 · AI
Improving the efficiency of clinic-based active tuberculosis case finding: evaluation of point-of-care C-reactive protein-based triage testing in Vietnam.
$204,886Christina Yoon · University Of California, San Francisco · R21 · FY2021 · AI
Sulfur Assimilation Pathway: New Antifungal Targets
$204,881Nina Agabian · University Of California, San Francisco · R21 · FY2009 · AI
Treatment Development for Smoking Cessation and Engagement in HIV/TB Care in South Africa
$204,866Conall Michael O'Cleirigh · Massachusetts General Hospital · R34 · FY2023 · DA
Roles of Rv0805 in biology of M. tuberculosis
$204,786Kathleen A. McDonough · Wadsworth Center · R21 · FY2019 · AI
Outcomes and Predictors of Successful Transition to Adult Care for HIV-infected Adolescents in South Africa
$204,782Brian C. Zanoni · Massachusetts General Hospital · R21 · FY2017 · HD
Core-001
$204,767Alessandro Sette · La Jolla Institute For Immunology · U19 · FY2020 · AI
PpiA, a multitasking mycobacterial virulence protein
$204,688William Ramses Bishai · Johns Hopkins University · R21 · FY2020 · AI
Regulation of allergen-induced mast cell activation and allergic inflammation through DCIR
$204,688Peisong Gao · Johns Hopkins University · R21 · FY2019 · AI
Oral dual β-lactams to treat pulmonary M. abscessus disease
$204,688Gyanu Lamichhane · Johns Hopkins University · R21 · FY2020 · AI
Exploiting a robust drug discovery portfolio to develop effective regimens to treat Mycobacterium abscessus lung infection
$204,688Eric L Nuermberger · Johns Hopkins University · R21 · FY2019 · AI
Measuring Intralesional Bedaquiline Exposures in Cavitary TB Using Noninvasive In Vivo PET Imaging
$204,688Sanjay Jain · Johns Hopkins University · R21 · FY2021 · AI
Immunotherapy Targeting MTB Persisters in the DC-impaired Setting of HIV and TB
$204,688Petros C Karakousis · Johns Hopkins University · R21 · FY2019 · AI
DEVELOP GENOMEWIDE TECHNOLOGY TO PROFILE DNA ADP-RIBOSYLATION
$204,688Anthony K L Leung · Johns Hopkins University · R21 · FY2024 · GM
Cryptococcal Exploitation of the Blood-Brain Barrier
$204,688Brendan Patrick Cormack · Johns Hopkins University · R21 · FY2021 · AI
TB goes viral: Interplay between mycobacteria RNA and host cytosolic surveillance pathways
$204,688William Ramses Bishai · Johns Hopkins University · R21 · FY2019 · AI
A strategy to treat M. abscessus infections
$204,688Gyanu Lamichhane · Johns Hopkins University · R21 · FY2019 · AI
Evaluation of PARP-1 as a target of host-directed therapy in tuberculosis
$204,687William Ramses Bishai · Johns Hopkins University · R21 · FY2019 · AI